Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1999
11/11/1999CA2295510A1 Use of a nuclease inhibitor or interleukin-10 (il-10) for the preparation of a therapeutic composition for improving transfection of a polynucleotide into a cell and compositions useful in gene therapy
11/11/1999CA2295323A1 Heparanase specific molecular probes and their use in research and medical applications
11/11/1999CA2248963A1 Novel compounds
11/11/1999CA2230991A1 Dna demethylase, therapeutic and diagnosic uses thereof
11/10/1999EP0955372A2 Method for screening substance inhibiting activation of NF-kappa B
11/10/1999EP0955366A1 Antigenic protein originating in malassezia
11/10/1999EP0955365A2 Crystallization of M-CSF
11/10/1999EP0955361A1 Monoclonal antibodies to tumor-associated antigens, methods for their production, and their use
11/10/1999EP0955314A2 Peptide analogues of glucagon-like-peptide-1 (7-37), their preparation and pharmaceutical compositions
11/10/1999EP0955313A1 Novel protein and process for producing the same
11/10/1999EP0955312A2 Antimicrobial peptide
11/10/1999EP0955309A1 Inhibitors and substrates of thrombin
11/10/1999EP0955062A1 Human growth hormone aqueous formulation
11/10/1999EP0955061A1 Oral product for the prevention and therapy of porcine gastroenteric infections
11/10/1999EP0955060A1 Remedies for acute pulmonary injuries due to indirect causes containing anti-il-8 antibody as the active ingredient
11/10/1999EP0955058A1 Lactoferrin tablets
11/10/1999EP0955057A1 Medicine as an aid for hypothermia
11/10/1999EP0955056A1 Recombinant colony stimulating factor-1 for treatment of fungal infection
11/10/1999EP0955055A2 FGF inhibitor, angiogenesis inhibitor and antitumor agent containing complestatin or its derivative as effective ingredient
11/10/1999EP0955054A1 Aids remedy
11/10/1999EP0954602A1 Hereditary hemochromatosis gene
11/10/1999EP0954593A1 Recombinant pox virus for immunization against tumor-associated antigens
11/10/1999EP0954591A2 Mini-adenoviral vector
11/10/1999EP0954588A1 Ob fusion protein compositions and methods
11/10/1999EP0954587A1 Expression in yeast of antigenically active, recombinant hybrid glutamic acid decarboxylase
11/10/1999EP0954586A1 Methods of reducing the levels of protoporphyrin ix in recombinant hemoglobin preparations
11/10/1999EP0954585A2 Human telomerase catalytic subunit
11/10/1999EP0954580A1 Human sdf-5 protein and compositions
11/10/1999EP0954578A1 Glycoprotein hormone superagonists
11/10/1999EP0954577A2 Secreted proteins and polynucleotides encoding them
11/10/1999EP0954576A2 Cd16-ii variants
11/10/1999EP0954575A2 Cerebellum and embryo specific protein
11/10/1999EP0954574A2 Oligonucleotides from the untranslated regions of housekeeping genes and methods of using same to modulate cell growth
11/10/1999EP0954573A1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation
11/10/1999EP0954570A1 A recombinant enzyme with mutanase activity
11/10/1999EP0954565A1 Adipogenic differentiation of human mesenchymal stem cells
11/10/1999EP0954564A1 Methods for generating cytotoxic t cells in vitro
11/10/1999EP0954537A2 Chitosan-conjugates with acidic chelate-complex forming agents
11/10/1999EP0954535A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use
11/10/1999EP0954532A1 Novel human apoptosis regulator
11/10/1999EP0954531A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
11/10/1999EP0954530A1 Immunomodulatory peptides of vespid antigen 5
11/10/1999EP0954529A1 Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
11/10/1999EP0954527A1 Glycine transporter-transfected cells and uses thereof
11/10/1999EP0954526A2 Serine protease inhibitors
11/10/1999EP0954525A1 Novel compounds
11/10/1999EP0954524A1 A process for purifying apolipoproteins and a composition for use in the process
11/10/1999EP0954519A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
11/10/1999EP0954340A1 Targeted combination immunotherapy of cancer
11/10/1999EP0954338A2 Cationic amphiphile/dna complexes
11/10/1999EP0954337A1 Intestinal absorption of nicotine to treat nicotine responsive conditions
11/10/1999EP0954334A1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy
11/10/1999EP0954333A2 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
11/10/1999EP0954331A1 Novel compounds
11/10/1999EP0954330A1 Intestinal trefoil proteins
11/10/1999EP0954328A1 Laminin-5 and the formation of basement membrane structure
11/10/1999EP0954327A1 Useful formulations of acid addition salt drugs
11/10/1999EP0954326A1 A process for viral inactivation of lyophilized blood proteins
11/10/1999EP0954324A1 Cyclic peptide vaccines for treatment and prevention of diabetes
11/10/1999EP0954317A2 Use of 7 apha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
11/10/1999EP0954292A1 Pharmaceutical formulations with delayed drug release
11/10/1999EP0954286A2 Liposomal influenza vaccine composition and method
11/10/1999EP0954282A1 Preparation of particles for inhalation
11/10/1999EP0954222A1 Gene therapy for proliferative vitreoretinopathy
11/10/1999EP0724588B1 Drug binding protein
11/10/1999EP0635026B1 Novel lipophilic oligopeptides with immunomodulating activity
11/10/1999EP0610487B1 New aminoacid derivates, process for producing the same and pharmaceutical compositions containing these compounds
11/10/1999EP0584256B1 Compounds and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors
11/10/1999CN1234835A Gene therapy for congestive heart failure
11/10/1999CN1234834A Methods for preventing graft rejection in transplantation and for producing universal gene therapy host cell
11/10/1999CN1234833A Nuetrokine 'alpha'
11/10/1999CN1234806A G protein-coupled receptor antagonists
11/10/1999CN1234805A ICE inhibiting peptides
11/10/1999CN1234742A Improvements in or relating to diagnostic/therapeutic agents and improvement relating to same
11/10/1999CN1234735A Method for treating skin pigmentation
11/10/1999CN1234443A Nereid kinase and its extraction method and use
11/10/1999CN1234406A Single-chain multiple antigen-binding molecule, its preparation and use
11/10/1999CN1234229A Apparatus for treatment of immunomediated inflammatory disorders
11/10/1999CN1046314C Monoclonal antibody with characteristics of causing programmatic death of cells
11/10/1999CN1046292C Method of chemical dressing hemoglobins used as oxygen carrier in blood substitution material
11/10/1999CN1046291C Protein Rib, process for purification of the protein, reagent kit and pharmaceutical composition
11/09/1999US5981844 Synergistic antifungal protein and compositions containing same
11/09/1999US5981732 Antisense oligonucleotides which target the expression of a g protein
11/09/1999US5981731 Anticarcinogenic/antitumor/antiproliferative agents and diagnostic agents targeted against gene which codes for a protein kinase involved in signal transduction
11/09/1999US5981726 Chimeric and mutationally stabilized tumor-specific B1, B3 and B5 antibody fragments; immunotoxic fusion proteins; and uses thereof
11/09/1999US5981725 Structural alterations of the EGF receptor gene in human tumors
11/09/1999US5981724 DNA encoding CD40 ligand, a cytokine that binds CD40
11/09/1999US5981720 Carrier glucosylated tetrapeptide comprising a tetrapeptide of glycine, asparagine, lysine and acetylglycosamine; as antidiabetic agents for non-insulin dependent diabetes and viricides to treat human immunodeficiency virus infections
11/09/1999US5981718 Polypeptide with reduced allergenicity
11/09/1999US5981717 Mammalian tolloid-like gene and protein
11/09/1999US5981716 Process for the purification of proteins
11/09/1999US5981714 Monoclonal antibodies which bind to specific epitopes; for detecting transport protein in biological samples; for purifying transport protein from an impure solution; for determining orientation in membrane of lipid vesicle
11/09/1999US5981713 Antibody specific for an epitope of an interleukin-1 receptor antagonist; antiinflammatory/anticarcinogenic agents; prophylactic, diagnostic, therapeutic agents for autoimmune diseases
11/09/1999US5981712 Antibody which binds to carboxyamido-triazole resistance protein; for detecting resistance to drug which prevents calcium influx in biological samples/cells
11/09/1999US5981711 Antibodies which bind to protein from putative oncogene; for probes and imaging agents used in diagnosis/prognosis of cancer/tumors; anticarcinogenic/antitumor agents and vaccines
11/09/1999US5981710 Therapeutic hemoglobin composition having isotropically increased size
11/09/1999US5981709 Conjugating an acid stable alpha-interferon with an activated non-antigenic polymer in solution, acidifying solution to selectively cleave linkages that reduce bioactivity, adjust solution to a physiological ph
11/09/1999US5981708 Rodent polypeptide which is an autocrine growth factor; for augmenting growth of hematopoeitic stem cells; for antitumor agents to control tumor cell growth
11/09/1999US5981707 Nucleotide and amino acid sequences of protein which binds to telomerase rna; for investigating aging and proliferation; antiproliferative agents
11/09/1999US5981705 Natural killer lytic associated protein
1 ... 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 ... 3163